BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33743481)

  • 1. Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.
    Seppälä TT; Dominguez-Valentin M; Crosbie EJ; Engel C; Aretz S; Macrae F; Winship I; Capella G; Thomas H; Hovig E; Nielsen M; Sijmons RH; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Mints M; Gluck N; Katz L; Heinimann K; Vaccaro CA; Green K; Lalloo F; Hill J; Schmiegel W; Vangala D; Perne C; Strauß HG; Tecklenburg J; Holinski-Feder E; Steinke-Lange V; Mecklin JP; Plazzer JP; Pineda M; Navarro M; Vida JB; Kariv R; Rosner G; Piñero TA; Pavicic W; Kalfayan P; Ten Broeke SW; Jenkins MA; Sunde L; Bernstein I; Burn J; Greenblatt M; de Vos Tot Nederveen Cappel WH; Della Valle A; Lopez-Koestner F; Alvarez K; Büttner R; Görgens H; Morak M; Holzapfel S; Hüneburg R; von Knebel Doeberitz M; Loeffler M; Redler S; Weitz J; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Hopper JL; Win AK; Lindor NM; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo JC; Thibodeau SN; Therkildsen C; Wadt KAW; Mourits MJE; Ketabi Z; Denton OG; Rødland EA; Vasen H; Neffa F; Esperon P; Tjandra D; Möslein G; Rokkones E; Sampson JR; Evans DG; Møller P
    Eur J Cancer; 2021 May; 148():124-133. PubMed ID: 33743481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.
    Dominguez-Valentin M; Crosbie EJ; Engel C; Aretz S; Macrae F; Winship I; Capella G; Thomas H; Nakken S; Hovig E; Nielsen M; Sijmons RH; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Mints M; Gluck N; Katz L; Heinimann K; Vaccaro CA; Green K; Lalloo F; Hill J; Schmiegel W; Vangala D; Perne C; Strauß HG; Tecklenburg J; Holinski-Feder E; Steinke-Lange V; Mecklin JP; Plazzer JP; Pineda M; Navarro M; Vidal JB; Kariv R; Rosner G; Piñero TA; Gonzalez ML; Kalfayan P; Ryan N; Ten Broeke SW; Jenkins MA; Sunde L; Bernstein I; Burn J; Greenblatt M; de Vos Tot Nederveen Cappel WH; Della Valle A; Lopez-Koestner F; Alvarez K; Büttner R; Görgens H; Morak M; Holzapfel S; Hüneburg R; von Knebel Doeberitz M; Loeffler M; Rahner N; Weitz J; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Auranen A; Hopper JL; Win AK; Haile RW; Lindor NM; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo JC; Thibodeau SN; Therkildsen C; Okkels H; Ketabi Z; Denton OG; Rødland EA; Vasen H; Neffa F; Esperon P; Tjandra D; Möslein G; Sampson JR; Evans DG; Seppälä TT; Møller P
    Genet Med; 2021 Apr; 23(4):705-712. PubMed ID: 33257847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness Analysis of Genotype-Specific Surveillance and Preventive Strategies for Gynecologic Cancers Among Women With Lynch Syndrome.
    Wright JD; Silver ER; Tan SX; Hur C; Kastrinos F
    JAMA Netw Open; 2021 Sep; 4(9):e2123616. PubMed ID: 34499134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database.
    Dominguez-Valentin M; Seppälä TT; Engel C; Aretz S; Macrae F; Winship I; Capella G; Thomas H; Hovig E; Nielsen M; Sijmons RH; Bertario L; Bonanni B; Tibiletti MG; Cavestro GM; Mints M; Gluck N; Katz L; Heinimann K; Vaccaro CA; Green K; Lalloo F; Hill J; Schmiegel W; Vangala D; Perne C; Strauß HG; Tecklenburg J; Holinski-Feder E; Steinke-Lange V; Mecklin JP; Plazzer JP; Pineda M; Navarro M; Vidal JB; Kariv R; Rosner G; Piñero TA; Gonzalez ML; Kalfayan P; Sampson JR; Ryan NAJ; Evans DG; Møller P; Crosbie EJ
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Risks for PMS2-Associated Lynch Syndrome.
    Ten Broeke SW; van der Klift HM; Tops CMJ; Aretz S; Bernstein I; Buchanan DD; de la Chapelle A; Capella G; Clendenning M; Engel C; Gallinger S; Gomez Garcia E; Figueiredo JC; Haile R; Hampel HL; Hopper JL; Hoogerbrugge N; von Knebel Doeberitz M; Le Marchand L; Letteboer TGW; Jenkins MA; Lindblom A; Lindor NM; Mensenkamp AR; Møller P; Newcomb PA; van Os TAM; Pearlman R; Pineda M; Rahner N; Redeker EJW; Olderode-Berends MJW; Rosty C; Schackert HK; Scott R; Senter L; Spruijt L; Steinke-Lange V; Suerink M; Thibodeau S; Vos YJ; Wagner A; Winship I; Hes FJ; Vasen HFA; Wijnen JT; Nielsen M; Win AK
    J Clin Oncol; 2018 Oct; 36(29):2961-2968. PubMed ID: 30161022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
    Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
    JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database.
    Dominguez-Valentin M; Haupt S; Seppälä TT; Sampson JR; Sunde L; Bernstein I; Jenkins MA; Engel C; Aretz S; Nielsen M; Capella G; Balaguer F; Evans DG; Burn J; Holinski-Feder E; Bertario L; Bonanni B; Lindblom A; Levi Z; Macrae F; Winship I; Plazzer JP; Sijmons R; Laghi L; Della Valle A; Heinimann K; Dębniak T; Fruscio R; Lopez-Koestner F; Alvarez-Valenzuela K; Katz LH; Laish I; Vainer E; Vaccaro C; Carraro DM; Monahan K; Half E; Stakelum A; Winter D; Kennelly R; Gluck N; Sheth H; Abu-Freha N; Greenblatt M; Rossi BM; Bohorquez M; Cavestro GM; Lino-Silva LS; Horisberger K; Tibiletti MG; Nascimento ID; Thomas H; Rossi NT; Apolinário da Silva L; Zaránd A; Ruiz-Bañobre J; Heuveline V; Mecklin JP; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Peltomäki P; Therkildsen C; Madsen MG; Burgdorf SK; Hopper JL; Win AK; Haile RW; Lindor N; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo J; Buchanan DD; Thibodeau SN; von Knebel Doeberitz M; Loeffler M; Rahner N; Schröck E; Steinke-Lange V; Schmiegel W; Vangala D; Perne C; Hüneburg R; Redler S; Büttner R; Weitz J; Pineda M; Duenas N; Vidal JB; Moreira L; Sánchez A; Hovig E; Nakken S; Green K; Lalloo F; Hill J; Crosbie E; Mints M; Goldberg Y; Tjandra D; Ten Broeke SW; Kariv R; Rosner G; Advani SH; Thomas L; Shah P; Shah M; Neffa F; Esperon P; Pavicic W; Torrezan GT; Bassaneze T; Martin CA; Moslein G; Moller P
    EClinicalMedicine; 2023 Apr; 58():101909. PubMed ID: 37181409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features of 50 mismatch repair (MMR)-deficient endometrial carcinomas, tested by immunohistochemistry: A single institutional feasibility study, India.
    Rekhi B; Menon S; Deodhar KK; Ghosh J; Chopra S; Maheshwari A
    Ann Diagn Pathol; 2020 Aug; 47():151558. PubMed ID: 32619922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome.
    Schmeler KM; Daniels MS; Soliman PT; Broaddus RR; Deavers MT; Vu TM; Chang GJ; Lu KH
    Obstet Gynecol; 2010 Feb; 115(2 Pt 2):432-434. PubMed ID: 20093870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.
    Mills AM; Liou S; Ford JM; Berek JS; Pai RK; Longacre TA
    Am J Surg Pathol; 2014 Nov; 38(11):1501-9. PubMed ID: 25229768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of care and outcomes of risk reducing surgery in women with pathogenic variants in non-BRCA and Lynch syndrome ovarian cancer susceptibility genes.
    Schwartz ZP; Li AJ; Walsh CS; Rimel BJ; Alvarado MM; Lentz SE; Cass I
    Gynecol Oncol; 2023 Jun; 173():1-7. PubMed ID: 37030072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch Syndrome in Thai Endometrial Cancer Patients.
    Manchana T; Ariyasriwatana C; Triratanachat S; Phowthongkum P
    Asian Pac J Cancer Prev; 2021 May; 22(5):1477-1483. PubMed ID: 34048176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
    Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
    Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
    Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
    Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Gynecologic Surgery at Time of Colectomy Benefits Women with Lynch Syndrome and Colon Cancer: A Markov Cost-Effectiveness Analysis.
    Ofshteyn A; Jiang B; Bingmer K; Nakayama JM; Gallego C; Giglia M; Stein SL; Steinhagen E
    Dis Colon Rectum; 2020 Oct; 63(10):1393-1402. PubMed ID: 32969882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics.
    Meiser B; Kaur R; Kirk J; Morrow A; Peate M; Wong WKT; McPike E; Cops E; Dowson C; Austin R; Fine M; Thrupp L; Ward R; Macrae F; Hiller JE; Trainer AH; Mitchell G;
    Fam Cancer; 2020 Oct; 19(4):337-346. PubMed ID: 32385704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.
    Parry S; Win AK; Parry B; Macrae FA; Gurrin LC; Church JM; Baron JA; Giles GG; Leggett BA; Winship I; Lipton L; Young GP; Young JP; Lodge CJ; Southey MC; Newcomb PA; Le Marchand L; Haile RW; Lindor NM; Gallinger S; Hopper JL; Jenkins MA
    Gut; 2011 Jul; 60(7):950-7. PubMed ID: 21193451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.